Healthcare provider profile · identity verified

Heather Mohr, DO

Internal Medicine · WEST DES MOINES, IA · NPI 1912010562

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	695	175
Atorvastatin Calcium	Atorvastatin Calcium	566	150
Losartan Potassium	Losartan Potassium	468	126
Omeprazole	Omeprazole	297	84
Amlodipine Besylate	Amlodipine Besylate	290	85
Simvastatin	Simvastatin	271	73
Hydrochlorothiazide	Hydrochlorothiazide	220	63
Lisinopril	Lisinopril	209	62
Metoprolol Succinate	Metoprolol Succinate	209	47
Gabapentin	Gabapentin	203	46
Pantoprazole Sodium	Pantoprazole Sodium	199	60
Rosuvastatin Calcium	Rosuvastatin Calcium	189	55
Ozempic	Semaglutide	176	27
Furosemide	Furosemide	171	46
Potassium Chloride	Potassium Chloride	167	50
Sertraline Hcl	Sertraline Hcl	161	43
Escitalopram Oxalate	Escitalopram Oxalate	160	48
Eliquis	Apixaban	142	31
Metformin Hcl	Metformin Hcl	128	35
Trazodone Hcl	Trazodone Hcl	115	33
Duloxetine Hcl	Duloxetine Hcl	107	28
Metoprolol Tartrate	Metoprolol Tartrate	103	27
Pravastatin Sodium	Pravastatin Sodium	103	29
Pregabalin	Pregabalin	102	36
Citalopram Hbr	Citalopram Hydrobromide	94	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	19
Alendronate Sodium	Alendronate Sodium	89	25
Metformin Hcl Er	Metformin Hcl	77	20
Atenolol	Atenolol	75	24
Bupropion Xl	Bupropion Hcl	73	17
Montelukast Sodium	Montelukast Sodium	73	21
Albuterol Sulfate Hfa	Albuterol Sulfate	72	32
Glimepiride	Glimepiride	71	15
Meloxicam	Meloxicam	70	20
Valacyclovir	Valacyclovir Hcl	70	29
Donepezil Hcl	Donepezil Hcl	66	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	17
Alprazolam	Alprazolam	57	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	14
Tramadol Hcl	Tramadol Hcl	54	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	53	43
Irbesartan	Irbesartan	53	15
Sumatriptan Succinate	Sumatriptan Succinate	51	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	50	17
Nortriptyline Hcl	Nortriptyline Hcl	49	12
Lorazepam	Lorazepam	48	14
Prednisone	Prednisone	48	37
Famotidine	Famotidine	47	12
Tamsulosin Hcl	Tamsulosin Hcl	47	19
Zolpidem Tartrate	Zolpidem Tartrate	47	20
Allopurinol	Allopurinol	46	12
Clonazepam	Clonazepam	46	11
Doxazosin Mesylate	Doxazosin Mesylate	46	11
Glipizide Er	Glipizide	45	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	12
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Memantine Hcl	Memantine Hcl	42	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	11
Azithromycin	Azithromycin	41	39
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Benazepril Hcl	Benazepril Hcl	39	suppressed
Spironolactone	Spironolactone	39	12
Estradiol	Estradiol	37	19
Fluticasone Propionate	Fluticasone Propionate	36	14
Celecoxib	Celecoxib	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Temazepam	Temazepam	34	11
Ipratropium Bromide	Ipratropium Bromide	33	11
Januvia	Sitagliptin Phosphate	33	suppressed
Methenamine Hippurate	Methenamine Hippurate	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	17
Nystatin	Nystatin	31	15
Venlafaxine Hcl Er	Venlafaxine Hcl	31	11
Acyclovir	Acyclovir	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Methylprednisolone	Methylprednisolone	26	23
Ondansetron Odt	Ondansetron	26	19
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	14
Ezetimibe	Ezetimibe	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Dilt-Xr	Diltiazem Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	15
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Carvedilol	Carvedilol	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Finasteride	Finasteride	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Amoxicillin	Amoxicillin	17	13
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Glipizide	Glipizide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Linzess	Linaclotide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	13
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Baclofen	Baclofen	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error